UnitedHealth Group's Q1 2015 earnings transcript shows strong results across the board, exceeding expectations in revenue and earnings per share.  Management's positive tone and upward guidance revisions, coupled with organic growth and improved cost management, suggest a positive outlook.  The Catamaran acquisition is expected to be accretive, but the integration and early impact of this acquisition will likely be a key focus for investors in the coming weeks.
[2]
